TG THERAPEUTICS, INC. (TGTX) — Operating Income

Annual figures by fiscal year, from SEC filings.

2011: -$882.0K2012: -$26.90M2013: -$22.97M2014: -$55.72M2015: -$63.18M2016: -$78.97M2017: -$118.71M2018: -$174.40M2019: -$169.06M2020: -$273.59M2021: -$344.77M2022: -$218.32M2023: $20.63M2024: $41.93M2025: $123.32M$123.32M
2011Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025$123.32M+194.1%
2024$41.93M+103.2%
2023$20.63M+109.5%
2022-$218.32M+36.7%
2021-$344.77M-26.0%
2020-$273.59M-61.8%
2019-$169.06M+3.1%
2018-$174.40M-46.9%
2017-$118.71M-50.3%
2016-$78.97M-25.0%
2015-$63.18M-13.4%
2014-$55.72M-142.6%
2013-$22.97M+14.6%
2012-$26.90M-2949.4%
2011-$882.0K